Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
HPV binding assay to laminin-332/integrin α6β4 on human keratinocytes
Sarah A. Brendle
,
Neil D. Christensen
Department of Pathology and Laboratory Medicine
Division of Experimental Pathology
Penn State Cancer Institute
Cancer Institute, Mechanisms of Carcinogenesis
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Department of Cell and Biological Systems
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'HPV binding assay to laminin-332/integrin α6β4 on human keratinocytes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Binding Assay
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Integrin
100%
Laminin 332
100%
Human Keratinocytes (HaCaT)
100%
Extracellular Matrix
62%
HPV11
37%
Binding Mechanism
25%
Receptor Binding
12%
Host Cell
12%
Human Tissue
12%
Internalization Mechanism
12%
Papillomavirus Infections
12%
HPV16
12%
Basement Membrane
12%
Biochemistry, Genetics and Molecular Biology
Keratinocyte
100%
Wart Virus
100%
Integrin
100%
Laminin
100%
Human Papillomavirus Type 11
37%
Binding Study
12%
Receptor Binding
12%
Human Papillomavirus Type 16
12%
Human Papillomavirus Type 18
12%
Basement Membrane
12%
Internalization
12%
Human Papillomavirus Type 45
12%
Receptor Blocking
12%